These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 187338
1. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors. Kelly PA, Asselin J, Caron MG, Raynaud JP, Labrie F. Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338 [Abstract] [Full Text] [Related]
2. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma. Labrie F, Kelly PA, Asselin J, Raynaud JP. Recent Results Cancer Res; 1976 Jan; (57):109-20. PubMed ID: 827798 [Abstract] [Full Text] [Related]
3. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Kelly PA, Asselin J, Caron MG, Labrie F, Raynaud JP. J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479 [Abstract] [Full Text] [Related]
4. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats. Smith RD, Hilf R, Senior AE. Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605 [Abstract] [Full Text] [Related]
5. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors. Tsai TL, Katzenellenbogen BS. Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032 [Abstract] [Full Text] [Related]
6. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor. Manni A, Trujillo JE, Pearson OH. Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182 [Abstract] [Full Text] [Related]
7. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259 [Abstract] [Full Text] [Related]
9. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Shafie SM, Hilf R. Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834 [Abstract] [Full Text] [Related]
10. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Kledzik GS, Bradley CJ, Marshall S, Campbell GA, Meites J. Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050 [Abstract] [Full Text] [Related]
11. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat. Gandilhon P, Melancon R, Djiane J, Kelly PA. J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078 [Abstract] [Full Text] [Related]
12. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors. De Coster R, Van Ginckel RF, Callens MJ, Goeminne NK, Janssens BL. Cancer Res; 1992 Mar 01; 52(5):1240-4. PubMed ID: 1737385 [Abstract] [Full Text] [Related]
13. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat. Heidemann PH, Wittliff JL, Calhoon RE, Boylan ES. J Toxicol Environ Health; 1981 Oct 01; 8(4):667-86. PubMed ID: 6802985 [Abstract] [Full Text] [Related]
14. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM. Clin Cancer Res; 2006 Jul 01; 12(13):4062-71. PubMed ID: 16818706 [Abstract] [Full Text] [Related]
15. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors. Rozhin J, Ludwig EH, Corombos J, Odden D, Horwitz JP, Hughes R, Hughes DE, Wilson E, Brooks SC. Cancer Res; 1983 Jun 01; 43(6):2611-7. PubMed ID: 6406049 [Abstract] [Full Text] [Related]
16. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors. Yoshida H, Fukuhara T, Yamashi S, Yoshida A, Fukunishi R, Tsuji M, Matsumoto K. Cancer Res; 1983 May 01; 43(5):2311-6. PubMed ID: 6403234 [Abstract] [Full Text] [Related]
17. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Arafah BM, Manni A, Pearson OH. Endocrinology; 1980 Nov 01; 107(5):1364-9. PubMed ID: 6253265 [No Abstract] [Full Text] [Related]
18. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors. Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG. Cancer Treat Rep; 1987 Nov 01; 71(11):1021-7. PubMed ID: 3119199 [Abstract] [Full Text] [Related]
19. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet. Aylsworth CF, Van Vugt DA, Sylvester PW, Meites J. Cancer Res; 1984 Jul 01; 44(7):2835-40. PubMed ID: 6426788 [Abstract] [Full Text] [Related]
20. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors. Gibson SL, Hilf R. Cancer Res; 1976 Oct 01; 36(10):3736-41. PubMed ID: 133755 [Abstract] [Full Text] [Related] Page: [Next] [New Search]